259 related articles for article (PubMed ID: 34736395)
1. Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells.
Rawat S; Dadhwal V; Mohanty S
BMC Dev Biol; 2021 Nov; 21(1):16. PubMed ID: 34736395
[TBL] [Abstract][Full Text] [Related]
2. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL
Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763
[TBL] [Abstract][Full Text] [Related]
3. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
4. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
6. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
[TBL] [Abstract][Full Text] [Related]
7. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory and immunogenic properties of mesenchymal stem cells derived from bovine fetal bone marrow and adipose tissue.
Huaman O; Bahamonde J; Cahuascanco B; Jervis M; Palomino J; Torres CG; Peralta OA
Res Vet Sci; 2019 Jun; 124():212-222. PubMed ID: 30925336
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic Heterogeneity of Human Mesenchymal Stem Cells Derived from Bone Marrow, Dental Pulp, Adipose Tissue, and Umbilical Cord.
Zhu X; Xu X; Shen M; Wang Y; Zheng T; Li H; Wang X; Meng J
Cell Reprogram; 2023 Aug; 25(4):162-170. PubMed ID: 37384924
[TBL] [Abstract][Full Text] [Related]
11. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
12. Influence of Donor's Age on Immunomodulatory Properties of Canine Adipose Tissue-Derived Mesenchymal Stem Cells.
Taguchi T; Borjesson DL; Osmond C; Griffon DJ
Stem Cells Dev; 2019 Dec; 28(23):1562-1571. PubMed ID: 31588862
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice.
Wu SCM; Zhu M; Chik SCC; Kwok M; Javed A; Law L; Chan S; Boheler KR; Liu YP; Chan GCF; Poon EN
Stem Cell Res Ther; 2023 Jun; 14(1):167. PubMed ID: 37357314
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia preconditioning elicit differential response in tissue-specific MSCs via immunomodulation and exosomal secretion.
Gupta S; Rawat S; Krishnakumar V; Rao EP; Mohanty S
Cell Tissue Res; 2022 Jun; 388(3):535-548. PubMed ID: 35316374
[TBL] [Abstract][Full Text] [Related]
15. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
Front Immunol; 2021; 12():686356. PubMed ID: 34484183
[TBL] [Abstract][Full Text] [Related]
16. Large-Scale Automated Hollow-Fiber Bioreactor Expansion of Umbilical Cord-Derived Human Mesenchymal Stromal Cells for Neurological Disorders.
Vymetalova L; Kucirkova T; Knopfova L; Pospisilova V; Kasko T; Lejdarova H; Makaturova E; Kuglik P; Oralova V; Matalova E; Benes P; Koristek Z; Forostyak S
Neurochem Res; 2020 Jan; 45(1):204-214. PubMed ID: 31828497
[TBL] [Abstract][Full Text] [Related]
17. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
[TBL] [Abstract][Full Text] [Related]
18. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue.
Heo JS; Choi Y; Kim HS; Kim HO
Int J Mol Med; 2016 Jan; 37(1):115-25. PubMed ID: 26719857
[TBL] [Abstract][Full Text] [Related]
19. Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential.
Barberini DJ; Freitas NP; Magnoni MS; Maia L; Listoni AJ; Heckler MC; Sudano MJ; Golim MA; da Cruz Landim-Alvarenga F; Amorim RM
Stem Cell Res Ther; 2014 Feb; 5(1):25. PubMed ID: 24559797
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
Front Immunol; 2020; 11():826. PubMed ID: 32435248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
